1. Home
  2. VIV vs ILMN Comparison

VIV vs ILMN Comparison

Compare VIV & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telefonica Brasil S.A.

VIV

Telefonica Brasil S.A.

HOLD

Current Price

$14.08

Market Cap

22.8B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$142.22

Market Cap

21.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIV
ILMN
Founded
1973
1998
Country
Brazil
United States
Employees
35010
8650
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.8B
21.6B
IPO Year
1998
2000

Fundamental Metrics

Financial Performance
Metric
VIV
ILMN
Price
$14.08
$142.22
Analyst Decision
Hold
Hold
Analyst Count
4
17
Target Price
$14.80
$124.24
AVG Volume (30 Days)
1.0M
1.5M
Earning Date
05-12-2026
04-30-2026
Dividend Yield
2.47%
N/A
EPS Growth
N/A
170.87
EPS
N/A
0.87
Revenue
N/A
$4,343,000,000.00
Revenue This Year
$9.22
$6.47
Revenue Next Year
$5.52
$5.58
P/E Ratio
$22.12
$164.07
Revenue Growth
N/A
N/A
52 Week Low
$9.73
$78.80
52 Week High
$17.26
$155.53

Technical Indicators

Market Signals
Indicator
VIV
ILMN
Relative Strength Index (RSI) 32.99 59.96
Support Level $11.81 $116.54
Resistance Level $16.46 $153.43
Average True Range (ATR) 0.34 6.15
MACD -0.19 0.52
Stochastic Oscillator 7.71 74.21

Price Performance

Historical Comparison
VIV
ILMN

About VIV Telefonica Brasil S.A.

Telefonica Brasil, known as Vivo, is the largest wireless carrier in Brazil with 103 million customers, which is equal to about 38% market share. The firm is strongest in the postpaid business, where it has 72 million customers, or about 40% share of this market. Wireless services and equipment contribute about 70% of total revenue. Vivo is the incumbent fixed-line telephone operator in Sao Paulo state and also owns an extensive fiber network across the country. The firm provides internet access to 8 million households on this network. The firm also sells pay-TV and phone services to its fixed-line customers. Finally, corporate data and IT services, including cloud computing support, contribute about 10% of total revenue.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: